Resultaten visas 1 - 10 / 38
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År

Rhabdomyolysis during concomitant ticagrelor and rosuvastatin - a breast cancer resistance protein -mediated drug interaction?

Referentgranskad
Öppen tillgång
DOI
10.1111/bcp.15684
Lehtisalo, Minna; Kiander, Wilma; Filppula, Anne M.; Deng, Feng; Kidron, Heidi; Korhonen, Mari; Sink...
British journal of clinical pharmacology2023

Infectious complications in patients receiving ticagrelor or clopidogrel before coronary artery bypass grafting

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jhin.2019.09.018
Dalén M., Biancari F., Perrotti A., Mariscalco G., Onorati F., Faggian G., Franzese I., Salsano A., ...
Journal of hospital infection2020

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel

Referentgranskad
Öppen tillgång
DOI
10.1111/jth.14689
Gasecka, Aleksandra; Nieuwland, Rienk; Budnik, Monika; Dignat-George, Francoise; Eyileten, Ceren; Ha...
Journal of thrombosis and haemostasis2020

CYP3A4*22 May Increase Bleeding Risk in Ticagrelor Users

Referentgranskad
Öppen tillgång
DOI
10.1111/bcpt.13884
Liedes, Hilkka; Pajula, Juha; Vuorinen, Anna-Leena ; De Pretis, Francesco; van Gils, Mark; Harno, Ka...
Basic and clinical pharmacology and toxicology2023

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Referentgranskad
DOI
10.1056/NEJMoa1908077
Steg, PG; Bhatt, D; Simon, T; Fox, K; Mehta, SR; Harrington, RA; Held, C; Andersson, M; Himmelmann, ...
The new england journal of medicine2019

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Referentgranskad
Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridde...
New England Journal of Medicine2019

Pharmacokinetic interactions and pharmacogenetics of clopidogrel, prasugrel and ticagrelor

Holmberg, Mikko
[M. Holmberg]2018

Pharmacokinetic interactions and pharmacogenetics of clopidogrel, prasugrel and ticagrelor

Holmberg, Mikko
Kliin lab2018

Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin

Referentgranskad
Öppen tillgång
DOI
10.1002/cpt.3067
Lehtisalo, Minna; Tarkiainen, E. Katriina; Neuvonen, Mikko; Holmberg, Mikko; Kiiski, Johanna I.; Lap...
Clinical pharmacology and therapeutics2023

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

Referentgranskad
DOI
10.1093/eurheartj/ehv116
Varenhorst C, Eriksson N, Johansson \303\205, Barratt BJ, Hagstr\303\266m E, \303\205kerblom A, Syv\...
European heart journal2015

Rhabdomyolysis during concomitant ticagrelor and rosuvastatin - a breast cancer resistance protein -mediated drug interaction?

Referentgranskad
Öppen tillgång
DOI
10.1111/bcp.15684
2023

Infectious complications in patients receiving ticagrelor or clopidogrel before coronary artery bypass grafting

Referentgranskad
Öppen tillgång
DOI
10.1016/j.jhin.2019.09.018
2020

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel

Referentgranskad
Öppen tillgång
DOI
10.1111/jth.14689
2020

CYP3A4*22 May Increase Bleeding Risk in Ticagrelor Users

Referentgranskad
Öppen tillgång
DOI
10.1111/bcpt.13884
2023

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Referentgranskad
DOI
10.1056/NEJMoa1908077
2019

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

Referentgranskad
2019

Pharmacokinetic interactions and pharmacogenetics of clopidogrel, prasugrel and ticagrelor

2018

Pharmacokinetic interactions and pharmacogenetics of clopidogrel, prasugrel and ticagrelor

2018

Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin

Referentgranskad
Öppen tillgång
DOI
10.1002/cpt.3067
2023

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

Referentgranskad
DOI
10.1093/eurheartj/ehv116
2015